National Quality Measures Clearinghouse | Initial management of abnormal cervical cytology (Pap test) and HPV test in adult and adolescent females: Institute for Clinical Systems Improvement.-

Institute for Clinical Systems Improvement



1.- Initial management of abnormal cervical cytology (Pap test) and HPV test in adult and adolescent females: percentage of women aged 21 years and older with a high-grade squamous intraepithelial lesion (HSIL) cervical cytological result who have a colposcopy with endocervical curettage (ECC) or LEEP within six months.

full-text:
National Quality Measures Clearinghouse | Initial management of abnormal cervical cytology (Pap test) and HPV test in adult and adolescent females: percentage of women aged 21 years and older with a high-grade squamous intraepithelial lesion (HSIL) cervical cytological result who have a colposcopy with endocervical curettage (ECC) or LEEP within six months.


2.- Initial management of abnormal cervical cytology (Pap test) and HPV test in adult and adolescent females: percentage of women aged 21 years and older with a low-grade squamous intraepithelial lesion (LSIL) cervical cytological result who have a colposcopy within six months.

full-text:
National Quality Measures Clearinghouse | Initial management of abnormal cervical cytology (Pap test) and HPV test in adult and adolescent females: percentage of women aged 21 years and older with a low-grade squamous intraepithelial lesion (LSIL) cervical cytological result who have a colposcopy within six months.



3.- Initial management of abnormal cervical cytology (Pap test) and HPV test in adult and adolescent females: percentage of women aged 21 years and older with an atypical squamous cells of undetermined significance (ASCUS) cervical cytological result with high-risk HPV type who have a follow-up colposcopy within six months. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Initial management of abnormal cervical cytology (Pap test) and HPV test in adult and adolescent females: percentage of women aged 21 years and older with an atypical squamous cells of undetermined significance (ASCUS) cervical cytological result with high-risk HPV type who have a follow-up colposcopy within six months.